Navigation Links
Good Hygiene Is Key to Preventing MRSA
Date:11/7/2007

College of American Pathologists recommends regular hand washing to decrease the spread of antibiotic-resistant staph infections

NORTHFIELD, Ill., Nov. 7 /PRNewswire-USNewswire/ -- Methicillin-resistant Staphylococcus aureus (MRSA) is a germ with a big name that is suddenly causing big problems for schools and communities across the nation. Commonly referred to as a "superbug," MRSA is a kind of bacteria that causes staph infections that do not respond to treatment with common antibiotics, such as penicillins. Until recently, cases of MRSA were most commonly seen in hospitals and healthcare facilities; however, a growing number of reported infections are now emerging in the general population.

"Whether it's in a hospital or at a school, MRSA is usually transmitted by direct skin-to-skin contact," said Kathleen G. Beavis, MD, FCAP, a pathologist at Stroger Hospital of Cook County (formerly Cook County Hospital) in Chicago, who specializes in microbiology and infectious diseases. "What most people may be unaware of is that an individual does not have to appear sick -- or present symptoms -- to carry this type of bacteria on their bodies. In fact, these individuals are the most common source of transmission."

In addition to direct contact with an infected person, MRSA bacteria can live on common surfaces, such as a table, for a day or weeks and can be transmitted when someone touches it. If a person does contract MRSA, the infection will most likely appear as a skin infection in the form of pustules or boils, which often are red, swollen, painful, or have pus or other drainage. These skin infections commonly occur at the sites of visible skin trauma, such as cuts and abrasions, and areas of the body covered by hair.

Most MRSA-related skin infections can be effectively treated, with or without antibiotics, by draining the pus. However, more than 94,000 Americans contracted MRSA infections in 2005, with nearly 19,000 of those cases asso
'/>"/>

SOURCE College of American Pathologists
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
2. London School of Hygiene to play key role in global collaboration on adverse drug reactions
3. Governor Rendell Declares Senior Smiles Day in Pennsylvania; Goal is to Improve Oral Hygiene for Senior Citizens
4. APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene
5. Blood-flow detector software show promise in preventing brain damage
6. Preventing variceal bleeding
7. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
8. Preventing or reducing enlarged heart decreases risk of heart failure
9. Pill Equals Injection in Preventing Clots After Hip Replacement
10. Treating obstructive sleep apnea, preventing heart attacks and strokes
11. Preventing lung scarring may extend lives of lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... MONROVIA, Calif., July 24 /PRNewswire-FirstC... leading developer, manufacturer and marketer of,m...nced that the Centers,for Medicare and Medicaid Se...heric cataract lenses as New Technology Intraocula...amer(R) Aspheric Single Piece foldable,intraocular...
(Date:7/24/2008)... Ground-breaking Technology Debuts in the Trance... Shoe, BOTHELL, Wash., July 24 /PRNewswi...Sports, Inc. today announced that BioMoGo, the wor... to consumers in the new Trance(TM),8 premium supp... times,faster than conventional athletic shoe mids...
(Date:7/24/2008)... NEW YORK, July 24 /PRNewswire/ -- MS -- Toda...nt things. For those who care for their,bodies, by...ations for,anti-aging, it is possible to feel and ...http://www.newscom.com/cgi-bin/prnh/20080724/NYFNS...uthor, and frequent guest on,Oprah Winfrey,s progr...
(Date:7/24/2008)... SCHAUMBURG, Ill., July 24 /PRNewswire/ -- A ...America,s most chronic problems -- obesity -- in,p... weight problem. About one third of us are,obese, ...ets -- they really,do look like us -- mirror us wi...esity, a public/private partnership that includes,...
Breaking Medicine News(10 mins):Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 2Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 3Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 4Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 2Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 3Health News:Live to 100 ... And Feel Great 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/23/2008)...py to Treat the Disease -, WAYNE, N.J. and EMERYV...yer HealthCare Pharmaceuticals and Onyx Pharmaceut...e New England Journal of Medicine published,result... (sorafenib),tablets decreased the absolute risk o...e hepatocellular carcinoma (HCC), or liver cancer,...
(Date:7/23/2008).../ -- The following was,released by the U.S. Depart...r Smith, and Members of the Committee.,Thank you f...eared before this Committee almost six months ago,...ented and dedicated professionals,at the Justice D...me to,appreciate that much more deeply their servi...
(Date:7/23/2008)...ode BioPharmaceutics, Inc.,an emerging biopharmac...results demonstrating the utility of their lead dr...hronic blood disorder paroxysmal nocturnal,hemoglo...ted at the XXII,International Complement Workshop ...nly treatment currently available for PNH patients...
(Date:7/22/2008)...irstCall/ -- Following a,thorough review that conc...uticals Limited (ASX: PGL; Nasdaq: PGLA) today ann...study in liver cancer. Progen confirmed,its strate... compounds and,the company will actively seek to a...ugh Merger & Acquisition activity., The strategic...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 1Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 2Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 1Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 2Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 4Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 5National Parkinson Foundation Announces Its New President and CEO 14689 1National Parkinson Foundation Announces Its New President and CEO 14689 2National Parkinson Foundation Announces Its New President and CEO 14689 3Michigan State Medical Society Will Present How VEBA is Shifting Michigans Health Care Gears 14686 1
... -- Additional Findings Reported Safety & Tole...and Healthy Subjects --, CHICAGO, June 25, 2007 /P...his week at the annual meeting of the American Dia...n inhibitor of,dipeptidyl-peptidase-4 (DPP-4) in d...raZeneca , in combination with metformin,exhibite...
... ,Focus On AV411,s Unique Mechanism of Action an...l Conditions , ALAMEDA, Calif., June 26, 2007 (PRI...harmaceutical company innovating therapeutics,for ...d today that,Expert Opinion on Investigational Dru...eline product, AV411 (ibudilast), a potential,firs...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
Our Tri-Flo® suction catheter design was created to be less traumatic to your patients while still providing high suctioning efficiency. Our infant and pediatric catheters (5/6, 8 or 10 Fr) featu
Tracheal Suction Latex Rubber Catheters - Funnel End
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip.
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning.
Medicine Products: